Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Large-scale testing (Phase 3)Active Not RecruitingNCT06430866
What this trial is testing

Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

Who this might be right for
Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen 163
Testing effectiveness (Phase 2)Study completedNCT00046839
What this trial is testing

Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 21
Not applicableUnknownNCT02950337
What this trial is testing

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Loyola University 41
Testing effectiveness (Phase 2)UnknownNCT05034133
What this trial is testing

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Beijing Haidian Hospital 20
Not applicableWithdrawnNCT01237171
What this trial is testing

Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer

Who this might be right for
NSCLCNon Small Cell Lung Cancer
IsoRay Medical, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06542159
What this trial is testing

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases

Who this might be right for
Adaptive RadiotherapyStereotactic Body RadiotherapyNon-small Cell Lung Cancer+2 more
Sun Yat-sen University 130
Testing effectiveness (Phase 2)UnknownNCT05443646
What this trial is testing

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Who this might be right for
Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Not applicableStudy completedNCT03429673
What this trial is testing

Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
China-Japan Friendship Hospital 10,885
Testing effectiveness (Phase 2)Looking for participantsNCT06911606
What this trial is testing

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
SCLC, Limited Stage
Guangdong Provincial People's Hospital 45
Large-scale testing (Phase 3)Study completedNCT00373425
What this trial is testing

Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors

Who this might be right for
Non-small Cell Lung Cancer
OSI Pharmaceuticals 1,252
Testing effectiveness (Phase 2)Ended earlyNCT00545948
What this trial is testing

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Duke University 31
Large-scale testing (Phase 3)Looking for participantsNCT06284317
What this trial is testing

Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
ETOP IBCSG Partners Foundation 290
Not applicableUnknownNCT03771404
What this trial is testing

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05904015
What this trial is testing

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Who this might be right for
Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Early research (Phase 1)UnknownNCT04882033
What this trial is testing

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Limited Stage
Tianjin Medical University Cancer Institute and Hospital 9
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Large-scale testing (Phase 3)Not Yet RecruitingNCT07637513
What this trial is testing

Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer

Who this might be right for
Limited Stage Small-Cell Lung Cancer
PrECOG, LLC. 430
Testing effectiveness (Phase 2)Ended earlyNCT00293332
What this trial is testing

Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Lung Cancer
University of California, San Francisco 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798947
What this trial is testing

A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC

Who this might be right for
Limited-stage Small-cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 120
Next Page